Cargando…
Significance of initial blood pressure and comorbidity for the efficacy of a fixed combination of an angiotensin receptor blocker and hydrochlorothiazide in clinical practice
BACKGROUND: Two-thirds of all patients with arterial hypertension need drug combinations to achieve blood pressure (BP) goals. Fixed combinations have high efficacy and result in high patient compliance. 300 mg irbesartan plus 25 mg hydrochlorothiazide (HCTZ) has been investigated only in clinical t...
Autores principales: | Schmieder, Roland E, Schwertfeger, Markus, Bramlage, Peter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788603/ https://www.ncbi.nlm.nih.gov/pubmed/19997579 |
Ejemplares similares
-
Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice
por: Bramlage, Peter, et al.
Publicado: (2014) -
Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension
por: Bramlage, Peter
Publicado: (2009) -
Safety, tolerability, and efficacy of a fixed-dose combination of olmesartan 40 mg and hydrochlorothiazide 12.5/25 mg in daily practice
por: Bramlage, Peter, et al.
Publicado: (2013) -
Office and ambulatory blood pressure control with a fixed-dose combination of candesartan and hydrochlorothiazide in previously uncontrolled hypertensive patients: results of CHILI CU Soon
por: Mengden, Thomas, et al.
Publicado: (2011) -
Efficacy and Safety of Combination Therapy Consisting of Angiotensin II Type 1 Receptor Blocker, Calcium Channel Blocker and Hydrochlorothiazide in Patients With Hypertension
por: Shiga, Yuhei, et al.
Publicado: (2017)